ACIP Backs Transition To Bivalent COVID-19 Vaccine, Flexibility On Number Of Annual Doses

 
• By Brenda Sandburg
  
Bivalent COVID-19 vaccine
The Bivalent formulation of the COVID-19 vaccine is on track to replace the monovalent formulation in the primary series. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet